Alexandre Lemoalle is a seasoned executive with over 20 years of experience in the pharmaceutical and biotech industries. He is the President of Amplei, a startup studio for rare diseases created by AFM-Téléthon, and a Managing Partner at Finpact. His expertise lies in finance, M&A, and strategic development, with a history at Sanofi and Genethon. He is a graduate of the ISG Institut Supérieur de Gestion.
Alexandre is dedicated to supporting innovations with high social and economic impact, particularly in the life sciences. He channels this passion through his leadership in ventures targeting rare diseases and by advising companies on strategic growth. His public activity shows strong support for charitable causes like the Téléthon and local community projects.
He has a specialized focus in the social and solidarity economy, advising entrepreneurs in this specific sector.
Read the full overview →They generally do not appreciate an overfriendly approach and prefer to stay to-the-point. It is quite likely of them to ask for pricing or other concessions. They prefer to do thorough analysis of any situation.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.